ANI PHARMACEUTICALS, INC Freight Costs (Deprecated 2018-01-31)
ANI PHARMACEUTICALS, INC (ANIP) reported Freight Costs (Deprecated 2018-01-31) of $81.42 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FreightCosts · last filed 2013-11-07
- ANI PHARMACEUTICALS, INC freight costs (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $81.42K, a 0.98% increase year-over-year.
- ANI PHARMACEUTICALS, INC freight costs (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $72.78K, a 17.37% decline year-over-year.
- ANI PHARMACEUTICALS, INC freight costs (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $80.62K.
- ANI PHARMACEUTICALS, INC freight costs (deprecated 2018-01-31) for the quarter ending 2012-06-30 was $88.07K.
| Period end | Freight Costs (Deprecated 2018-01-31) 3 month | Freight Costs (Deprecated 2018-01-31) 6 month | Freight Costs (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2013-09-30 | $81.42K 10-Q · filed 2013-11-07 | $154.19K derived: sum of 2 quarters · filed 2013-11-07 | $224.19K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $72.78K 10-Q · filed 2013-08-09 | $142.77K 10-Q · filed 2013-08-09 | |
| 2012-09-30 | $80.62K 10-Q · filed 2013-11-07 | $168.69K derived: sum of 2 quarters · filed 2013-11-07 | $242.81K 10-Q · filed 2013-11-07 |
| 2012-06-30 | $88.07K 10-Q · filed 2013-08-09 | $162.19K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |